The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck KGaA; MSD; Novartis; Pharmaca; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Roche
A multicenter, phase II study of soluble LAG-3 (Eftilagimod Alpha) in combination with pembrolizumab (TACTI-002) in patients with advanced non-small cell lung cancer (NSCLC) or head and neck squamous cell carcinoma (HNSCC).
 
Julio Antonio Peguero
No Relationships to Disclose
 
Pawan Bajaj
No Relationships to Disclose
 
Enric Carcereny
No Relationships to Disclose
 
Timothy Dudley Clay
Honoraria - Merck Serono; Mundipharma; Novartis
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
 
Bernard Doger
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Lilly; MSD; Novartis; Pfizer; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - EMD Serono (Inst)
 
Matthew Krebs
Honoraria - Roche
Consulting or Advisory Role - Achilles Therapeutics; Janssen; Octimet; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BerGenBio
 
Martin Forster
No Relationships to Disclose
 
Santiago Ponce Aix
Consulting or Advisory Role - Roche
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - MSD
 
Patricia Roxburgh
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); FORMA Therapeutics (Inst); Iovance Biotherapeutics (Inst); Nucana (Inst); PsiOxus Therapeutics (Inst); Replimune (Inst); Sierra Oncology (Inst); Tesaro (Inst)
 
Frederic Triebel
Employment - Immutep
Leadership - Immutep
Stock and Other Ownership Interests - Immutep